中科微点-全球专利检索

  1. Login
  2. Sign Up
Invention Grant
US09024042B2 Reduced central corneal thickening by use of hydrophilic ester prodrugs of beta-chlorocyclopentanes 有权
通过使用β-氯环戊烷的亲水酯前药减少中心角膜增厚

  • Patent Title: Reduced central corneal thickening by use of hydrophilic ester prodrugs of beta-chlorocyclopentanes
  • Patent Title (中): 通过使用β-氯环戊烷的亲水酯前药减少中心角膜增厚
  • Application No.: US13974975
    Application Date: 2013-08-23
  • Publication No.: US09024042B2
    Publication Date: 2015-05-05
  • Inventor: Wha-Bin Im , Robert M. Burk
  • Applicant: Allergan, Inc.
  • Applicant Address: US CA Irvine
  • Assignee: Allergan, Inc.
  • Current Assignee: Allergan, Inc.
  • Current Assignee Address: US CA Irvine
  • Agent Jonathan Y. Bass
  • Main IPC: A61K9/00
  • IPC: A61K9/00 ;  A61K31/381 ;  C07D333/38
Reduced central corneal thickening by use of hydrophilic ester prodrugs of beta-chlorocyclopentanes
Abstract:
Compositions and methods for treating glaucoma are provided. In particular hydrophilic ester prodrugs and their use to reduce central corneal thickening is provided.
Abstract(Chinese):

提供了治疗青光眼的组合物和方法。 特别提供亲水性酯前体药物及其减少中心角膜增厚的用途。

Public/Granted literature
Information query
Espacenet
Patent Agency Ranking
0/0